✉news HealthMedicine first seen 9 h ago, last 15 min ago, peak #15
FDA to spotlight aging and longevity medicine in FARS updates
Original: FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates
The FDA plans to use upcoming updates to the Federal Adverse Reactions Reporting System framework to draw attention to aging and longevity medicine. According to Genetic Engineering and Biotechnology News, the agency intends to highlight how older adults respond to treatments and how longevity-focused therapies are tracked. The move signals growing regulatory interest in aging as a medical field and could shape how longevity drugs and interventions are evaluated and reported in the United States.
Why now: Longevity medicine is a fast-growing field and regulatory attention from the FDA signals potential changes for drug developers and aging research.
Rank over time, top of the chart is #1. 8 snapshots from 9 h ago to 15 min ago.
Evidence
- FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates · Genetic Engineering and Biotechnology News
API: https://socialmediatrends-api.osmike.com/v1/trends/801605